$3.22
0.289.52%
Last update: Aug 21, 7:58 PM
$3.27
0.3311.14%
Scinai Immunotherapeutics Ltd (SCNI) Stock Price, Quote, News & History
SCNINASDAQ
Stock Split: Scinai Immunotherapeutics Ltd is expected to split
Friday, August 21, 2026 with a ratio of
1:10
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Scinai Immunotherapeutics (SCNI) stock?
You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.
Who are Scinai Immunotherapeutics (SCNI) competitors?
Other companies in Scinai Immunotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Scinai Immunotherapeutics (SCNI) stock?
There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.
What is the current price for Scinai Immunotherapeutics (SCNI)?
The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $3.2676 last updated August 21, 2026 at 7:58 PM EDT.
Does Scinai Immunotherapeutics (SCNI) pay a dividend?
There are no upcoming dividends for Scinai Immunotherapeutics.
When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?
Scinai Immunotherapeutics does not have any upcoming earnings scheduled.
Is Scinai Immunotherapeutics (SCNI) going to split?
There is no upcoming split for Scinai Immunotherapeutics.
What sector and industry does Scinai Immunotherapeutics (SCNI) operate in?
Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
